Design for Success: Developability & Technology Selection

An optimal formulation is the simplest option that meets the product and patient’s needs. A technology agnostic approach based on a fundamental understanding of API properties, a well-defined yet flexible target product profile, and a mindset for scalability and commercial relevance leads to success in formulation development and drug product design.

In this webinar, Dr. Schlesinger will discuss how to use this approach to strategically guide formulation technology selection. When an enabled formulation is required, we’ll discuss how these same tools can further help to guide formulation development and product design.

Watch On-Demand

Erica Schlesinger, PhD

Vice President of Technical Development, Process and Product Development

Erica Schlesinger is Serán’s Vice President of Technical Development. She leads a team that applies scientific rationale and engineering design to problem-solving and pharmaceutical product development. Her research interests include spray-dried biologics (mAb, Phage, Virus, Whole Cells) and controlled-release technologies for long-acting therapeutics.

Erica has over 15 years of experience in pharmaceutical formulation development, process chemistry, and the early-stage development of novel drug delivery systems, and prior to joining Serán, she worked at Genentech, Seattle Genetics, and Regeneron.

Erica holds an undergraduate degree in Chemical Engineering from Cornell University and a Ph.D. in Bioengineering from the Joint Graduate Group in Bioengineering at the University of California San Francisco and UC Berkeley.

About Serán

Serán's Science-First Approach

Serán Bioscience is a science-based CDMO that specializes in a variety of drug delivery and formulation approaches suited to optimizing bioavailability. Our experienced formulation team will work with you to identify an appropriate technology and formulation strategy to meet your program’s unique needs. We take a comprehensive approach to formulation design that considers the physiochemical properties of the API, the target product profile, and your program’s objectives and constraints to develop scalable formulations using efficient and material-sparing approaches.

What Our Customers Are Saying

Delivering you the simplest approach to meet your program's needs.

When I think of Solubility Problems, I think of Serán.

Consultant

Consultant, Multiple Clients

Make a batch on time. Reliable CDMO, quality product within the timelines.

Large Pharma

Customers come for the flexibility and stay for the dedication.

Small Biotech

I’ve been impressed with Serán. One of the things we really look for is flexibility. They are a good combination of flexibility and technical competence.

Medium Size Pharma

The scientists we met at Serán were top notch.